Congress Takes First Look at User Fee Program for OTC Drugs
By Michael Mezher -
Published 13 September 2017
The House Energy & Commerce committee on Wednesday held its first hearing on a bill to reform the US Food and Drug Administration's (FDA) over-the-counter (OTC) drug monograph process by creating a new user fee program and offering marketing exclusivity for innovations to monograph products.
Categories: News, US, FDA, Over the counter drugs
Tags: OTC Monograph, OMOR, Over-the-Counter Monograph, User Fees